Do no do examples

Do no do examples for Chronic kidney disease in adults: assessment and management
Title Year published Impact Level
Do not diagnose CKD in people with: an eGFRcreatinine of 45 59 ml/min/1.73 m2 and an eGFRcystatinC of more than 60 ml/min/1.73 m2 and no other marker of kidney disease. July 2014 Unclassified
Do not use reagent strips to identify proteinuria unless they are capable of specifically measuring albumin at low concentrations and expressing the result as an ACR. July 2014 Unclassified
Do not use urine microscopy to confirm a reagent strip positive result when testing for the presence of haematuria. July 2014 Unclassified
Do not use age, gender or ethnicity as risk markers to test people for CKD. July 2014 Unclassified
In the absence of metabolic syndrome, diabetes or Hypertension, do not use obesity alone as a risk marker to test people for CKD. July 2014 Unclassified
Do not determine management of CKD solely by age. July 2014 Unclassified
Do not offer low-protein diets (dietary protein intake less than 0.6 0.8 g/kg/day) to people with CKD. July 2014 Unclassified
Do not offer a combination of renin angiotensin system antagonists to people with CKD. July 2014 Unclassified
Do not routinely offer a renin angiotensin system antagonist to people with CKD if their pretreatment serum potassium concentration is greater than 5.0 mmol/litre. July 2014 Unclassified
Do not routinely measure calcium, Phosphate, parathyroid hormone (PTH) and vitamin D levels in people with a GFR of 30 ml/min/1.73 m2 or more (GFR category G1, G2 or G3). July 2014 Unclassified
Do not routinely offer vitamin D supplementation to manage or prevent CKD mineral and bone disorders. July 2014 Unclassified
Do not modify the renin angiotensin system antagonist dose if the change in eGFR is less than 25% or the change in serum creatinine is less than 30%. July 2014 Unclassified